This clinical case study describes the velopharyngeal anatomy and physiology in a patient who presented with SATB2-associated syndrome (SAS) and velopharyngeal insufficiency (VPI) in the absence of an overt cleft palate. The clinical presentation, treatment, outcome, and the contribution of anatomical findings from MRI to surgical treatment planning for this rare genetic disorder, SAS, are described. This case study contributes to our current understanding of the anatomy and physiology of the velopharyngeal mechanism in an individual born with SAS and non-cleft VPI. It also details the changes following bilateral buccal myomucosal flaps in this patient.
ZarateYAFishJL. SATB2-associated syndrome: mechanisms, phenotype, and practical recommendations. Am J Med Genet A. 2017;173(2):327-337.
2.
ZarateYASmith-HicksCLGreeneC, et al.Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome. Am J Med Genet A. 2018;176(4):925-935.
3.
ZarateYABosankoKACaffreyAR, et al.Mutation update for the SATB2 gene. Hum Mutat. 2019;40(8):1013-1029.
4.
ZarateYAKalsnerLBasingerA, et al.Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome. Clin Genet. 2017;92(4):423-429.
5.
LeeJSYooYLimBCKimKJChoiMChaeJH. SATB2-associated syndrome presenting with Rett-like phenotypes. Clin Genet. 2016;89(6):728-732.
6.
DöckerDSchubachMMenzelM, et al.Further delineation of the SATB2 phenotype. Eur J Hum Genet. 2014;22(8):1034-1039.
7.
LeoyklangPSuphapeetipornKSrichomthongC, et al.Disorders with similar clinical phenotypes reveal underlying genetic interaction: SATB2 acts as an activator of the UPF3B gene. Hum Genet. 2013;132(12):1383-1393.
8.
LiedénAKvarnungMNilsssonDSahlinELundbergES. Intragenic duplication—A novel causative mechanism for SATB2-associated syndrome. Am J Med Genet A. 2014;164(12):3083-3087.
9.
KaiserASMaasBWolffA, et al.Characterization of the first intragenic SATB2 duplication in a girl with intellectual disability, nearly absent speech and suspected hypodontia. Eur J Hum Genet. 2015;23(5):704-707.
10.
FitzPatrickDRCarrIMMcLarenL, et al.Identification of SATB2 as the cleft palate gene on 2q32–q33. Hum Mol Genet. 2003;12(19):2491-2501.
11.
VieiraARAvilaJRDaack-HirschS, et al.Medical sequencing of candidate genes for nonsyndromic cleft lip and palate. PLoS Genet. 2005;1(6):e64.
12.
GurramkondaVBSyedAHMurthyJLakkakulaBV. SATB2 Gene variants in non-syndromic cleft lip with or without cleft palate in Indian population. J Oral Biol Craniofacial Res. 2015;5(3):161-164.
13.
Van BuggenhoutGVan Ravenswaaij-ArtsCMaasNM, et al.The del (2)(q32. 2q33) deletion syndrome defined by clinical and molecular characterization of four patients. Eur J Med Genet. 2005;48(3):276-289.
14.
de RavelTJBalikovaIThiryPVermeeschJRFrijnsJP. Another patient with a de novo deletion further delineates the 2q33. 1 microdeletion syndrome. Eur J Med Genet. 2009;52(2-3):120-122.
15.
UrquhartJBlackGCClayton-SmithJ. 4.5 Mb microdeletion in chromosome band 2q33. 1 associated with learning disability and cleft palate. Eur J Med Genet. 2009;52(6):454-457.
16.
RifaiLPort-LisMTabetAC, et al.Ectodermal dysplasia-like syndrome with mental retardation due to contiguous gene deletion: further clinical and molecular delineation of del (2q32) syndrome. Am J Med Genet A. 2010;152(1):111-117.
17.
BalasubramanianMSmithKBasel-VanagaiteL, et al.Case series: 2q33. 1 microdeletion syndrome—further delineation of the phenotype. J Med Genet. 2011;48(5):290-298.
18.
Mc CormackATaylorJGregersenNGeorgeAMLoveDR. Delineation of 2q32q35 deletion phenotypes: two apparent “proximal” and “distal” syndromes. Case Rep Genet. 2013;2013:823451.
19.
TomaszewskaAPodbiol-PalentaABoterM, et al.Deletion of 14.7 Mb 2q32. 3q33. 3 with a marfanoid phenotype and hypothyroidism. Am J Med Genet A. 2013;161(9):2347-2351.
20.
YuNShinSLeeKA. First Korean case of SATB2-associated 2q32-q33 microdeletion syndrome. Ann Lab Med. 2015;35(2):275-278.
21.
Gregoric KumperscakHKrgovicDVokacNK. Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32. 2q33. 1. J Int Med Res. 2016;44(2):395-402.
22.
Snijders BlokLGoosenYMvan HaaftenL, et al.Speech-language profiles in the context of cognitive and adaptive functioning in SATB2-associated syndrome. Genes Brain Behav. 2021;20(7):e12761.
23.
ThomasonAPankeyENuttBCaffreyARZarateYA. Speech, language, and feeding phenotypes of SATB2-associated syndrome. Clin Genet. 2019;96(6):485-492.
24.
ChapmanKLBaylisATrost-CardamoneJ, et al.The Americleft Speech Project: a training and reliability study. Cleft Palate Craniofac J. 2016;53(1):93-108.
MacKayIRA. The MacKay Kummer SNAP Test. Linc Park NJ Kay Elemetrics Corp. Published online 1994.
27.
PerryJLKollaraLKuehnDPSuttonBPFangX. Examining age, sex, and race characteristics of velopharyngeal structures in 4-to 9-year-old children using magnetic resonance imaging. Cleft Palate Craniofac J. 2018;55(1):21-34.
28.
HensGSellDPinkstoneM, et al.Palate lengthening by buccinator myomucosal flaps for velopharyngeal insufficiency. Cleft Palate Craniofac J. 2013;50(5):84-91.
29.
KollaraLSchenckGJaskolkaMPerryJL. Examining a new method to studying velopharyngeal structures in a child with 22q11. 2 deletion syndrome. J Speech Lang Hear Res. 2017;60(4):892-896.
30.
KollaraLBaylisALKirschnerRE, et al.Velopharyngeal structural and muscle variations in children with 22q11. 2 deletion syndrome: an unsedated MRI study. Cleft Palate Craniofac J. 2019;56(9):1139-1148.
31.
KollaraLBaylisALKirschnerRE, et al.Interaction of the craniofacial complex and velopharyngeal musculature on speech resonance in children with 22q11. 2 deletion syndrome: an MRI analysis. J Plast Reconstr Aesthet Surg. 2021;74(1):174-182.
32.
HaensslerAEBaylisAPerryJLKollaraLFangXKirschnerR. Impact of cranial base abnormalities on cerebellar volume and the velopharynx in 22q11. 2 deletion syndrome. Cleft Palate Craniofac J. 2020;57(4):412-419.
33.
KotlarekKJKotlarekJRReitnauerPJ, et al.A familial case study exploring craniofacial, velopharyngeal, and speech variations in Pierre Robin sequence. Clin Arch Commun Disord. 2018;3(3):236-245.
